Home » Newsletters » BioWorld Science

BioWorld Science

Dec. 13, 2012

View Archived Issues

Catabasis Pharmaceuticals synthesizes novel inhibitors of NF-kappaB signaling

Fred Hutchinson and GSK partner to develop muscular dystrophy therapeutics

Stemline Therapeutics describes MAb conjugate against IL-3R-alpha

PDC Biotech completes phase I trial of PDC-13 in primary dysmenorrhea

Sucampo receives milestone payment for first sale of Amitiza in Japan

Anacor discloses results from phase II trial of AN-2728

Pharmascience regains global rights to IAP inhibitor oncology program

Phase IIb study commences for inhaled LAMA candidate for the treatment of COPD

Interim data from phase I study of IPH-2101 plus lenalidomide reported

Durata Therapeutics reports phase III data for dalbavancin

uniQure begins phase I study in acute intermittent porphyria

KaloBios Pharmaceuticals KB-003 for chronic myelomonocytic leukemia

New phase IIb study of Zorcell psoriasis vaccine begins

Medicago receives support for influenza vaccine programs

Dosing begins in CUPID trial of Mydicar in advanced heart failure

Researchers design potent domain antibody inhibitors of amyloid formation

TiGenix presents novel immunomodulatory cells for MS

New fusion proteins disclosed by the National Institute of Immunology

Researchers at Bristol-Myers Squibb synthesize new HCV NS5A inhibitors

FORMA Therapeutics patents new NAmPRTase inhibitors

Eli Lilly shifts focus of phase III solanezumab trials

Vernalis' study of V-81444 confirms dose for proof-of-concept trial

Boehringer Ingelheim discontinues phase II dabigatran etexilate trial

Novel GR antagonists discovered to prevent antipsychotic-induced weight gain

NADPH oxidase 4 identified as therapeutic target in asthma

New product for congenital factor XIII deficiency launched

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 25, 2026.
Have brain-computer interfaces finally arrived?
BioWorld
More and more individuals now have chronically implanted brain-computer interface (BCI) systems in their heads. Devices that can record and stimulate neural...
News in brief
BioWorld Asia
BioWorld Asia briefs for June 23, 2026
Brain-computer interfaces are here but long road ahead
BioWorld
The field of BCI is continually evolving; as such, companies are increasingly highlighting the potential of their technologies to transform care. For advanced...
2026 marks critical turning point for BCI technology
BioWorld
Decades of research are helping unravel the “black box” of the brain. The second article in BioWorld’s series on the Brain-Computer Interface (BCI) field looks at...